Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ICD | Restricted Stock Units | Award | +654K | +16519.35% | 658K | Mar 18, 2022 | Common Stock | 654K | Direct | F1 | |||
transaction | ICD | Stock Appreciation Right | Award | +654K | 654K | Mar 18, 2022 | Common Stock | $654K | $5.19 | Direct | F2 |
Id | Content |
---|---|
F1 | Reporting person was granted an RSU that vests in 1/3 increments on (i) the one year anniversary of the date of grant, (ii) 12/31/23 and (iii) 12/31/24. The RSUs are subject to approval by the Company's stockholders of an amendment to increase the shares authorized for issuance under the Company's 2019 LTIP Plan. |
F2 | The reporting person was granted a stock appreciation right, 1/3 vests on the first anniversary of the date of grant and the remaining SARs vest in equal quarterly installments during the second and third years following the date of grant. Each SAR entitles the Reporting Person to receive shares of Common Stock upon exercise equal in value to the difference between the fair market value of the common stock on the date of exercise and the Strike Price of $5.19 per share. The SARS are subject to approval by the Company's stockholders of an amendment to to increase the shares authorized for issuance under the Company's 2019 LTIP Plan. |